Boehringer Ingelheim has announced that it intends to make drug data from clinical trials stemming back to 1998 accessible as part of efforts to improve research transparency within the industry.

The move is part of a collaboration with fellow pharma companies Sanofi, GlaxoSmithKline, Novartis, Roche and ViiV Healthcare on an online platform to handle requests from researchers for trial data.

Boehringer’s chairman Dr Andreas Barner made the announcement at Boehringer’s annual company meeting yesterday, following up from a commitment to transparency announced at the same meeting in 2013.

Dr Barner, who also heads R&D at Boehringer, explained that the online platform – available at clinicalstudydatarequest.com – currently contained 50 trials available for which to request patient-level data, but the plan is to reach 500 from all involved parties.

“That’s quite a job to achieve. but we have to do it in interest of what data and information can be shared with others,” said Dr Barner.

“We have always argued in favour of transparency and now want a more scientific discussion on the level of trial data and have therefore joined up with several research-based pharmaceutical companies in order to make clinical trials data and documents available to a wider public.” ….

read on in the original post here

See on www.pmlive.com